Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Health Records, Personal × 1 year × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Smoke Inhalation Injury 1 Respiratory Aspiration 1 Neoplasms 1 Lung Neoplasms 1 Lung Diseases, Interstitial 1 Lung Diseases 1 Brain Neoplasms 1

Interventions

pembrolizumab 87 Blood Specimen Collection 45 Cyclophosphamide 38 Nivolumab 35 Bevacizumab 35 Standard of Care 32 Carboplatin 32 Paclitaxel 31 Surveys and Questionnaires 28 atezolizumab 27 Fluorouracil 25 Cisplatin 25 Pemetrexed 23 Leucovorin 23 Gemcitabine 23 Oxaliplatin 22 Exercise 22 Docetaxel 21 Radiotherapy 20 Dexamethasone 20 Irinotecan 18 Cetuximab 17 fludarabine 15 Rituximab 15 Drug Therapy 15 Doxorubicin 15 dostarlimab 14 Capecitabine 14 Biopsy 14 durvalumab 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04732273 2025-09-23

SCCSS-FU

University of Bern

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡